Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph K Han

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
The Journal of Allergy and Clinical Immunology|August 16, 2024
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNPClaus Bachert, Asif H Khan, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2023
Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective-a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy CommitteeSeong H Cho, Anil Nanda, Anjeni Keswani, et al.
International Forum of Allergy & Rhinology|January 6, 2026
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 29, 2022
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studiesClaus Bachert, Anju T Peters, Enrico Heffler, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2021
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trialClaus Bachert, Joseph K Han, Martin Y Desrosiers, et al.
International Forum of Allergy & Rhinology|April 17, 2026
Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 12, 2012
Clinical consensus statement: appropriate use of computed tomography for paranasal sinus diseaseGavin Setzen, Berrylin J Ferguson, Joseph K Han, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countClaus Bachert, Ana R Sousa, Joseph K Han, et al.
The Laryngoscope|December 1, 2021
Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal PolyposisJoseph K Han, Claus Bachert, Stella E Lee, et al.
ERJ Open Research|December 1, 2022
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polypsShahid Siddiqui, Claus Bachert, Adam M Chaker, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Allergy and Clinical Immunology|August 16, 2024
Dupilumab response onset, maintenance, and durability in patients with severe CRSwNPClaus Bachert, Asif H Khan, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2023
Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective-a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy CommitteeSeong H Cho, Anil Nanda, Anjeni Keswani, et al.
International Forum of Allergy & Rhinology|January 6, 2026
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 29, 2022
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studiesClaus Bachert, Anju T Peters, Enrico Heffler, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2021
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trialClaus Bachert, Joseph K Han, Martin Y Desrosiers, et al.
International Forum of Allergy & Rhinology|April 17, 2026
Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 12, 2012
Clinical consensus statement: appropriate use of computed tomography for paranasal sinus diseaseGavin Setzen, Berrylin J Ferguson, Joseph K Han, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countClaus Bachert, Ana R Sousa, Joseph K Han, et al.
The Laryngoscope|December 1, 2021
Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal PolyposisJoseph K Han, Claus Bachert, Stella E Lee, et al.
ERJ Open Research|December 1, 2022
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polypsShahid Siddiqui, Claus Bachert, Adam M Chaker, et al.
Pageof 14